InnovaHealth Partners, a private equity firm, led a $73m funding round in Monteris Medica, a medical technology company, with participation from Birchview Capital. "Brain tumor and drug-resistant epilepsy patients and their physicians are looking for less invasive options when making their treatment decisions. NeuroBlate has been proven to offer a less invasive option for patients considering open brain surgery and is also a valuable minimally invasive tool to address surgical locations in the brain that are not accessible with more invasive traditional methods. The Monteris Medical team is pleased to add InnovaHealth and Madryn as financial partners, allowing us to further expand our efforts to bring the value of the NeuroBlate technology to more physicians and the patients we collectively serve," Martin J. Emerson, Monteris Medical President and CEO.